Neurological Disorders Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Neurological Disorders stocks.

Neurological Disorders Stocks Recent News

Date Stock Title
Jun 25 IONS Ionis gains as anti-lipid therapy undergoes FDA priority review
Jun 25 NLSP Nasdaq Panel Grants NLS Pharmaceutics' Request for Extension to Comply with Continued Listing Requirements
Jun 25 HRMY HARMONY BIOSCIENCES ACKNOWLEDGES U.S. FOOD & DRUG ADMINISTRATION (FDA) ACTION DENYING THE CITIZEN PETITION FOR WAKIX® (PITOLSIANT)
Jun 25 IONS Ionis announces olezarsen FCS New Drug Application accepted for Priority Review and enrollment in Phase 3 sHTG program completed
Jun 25 IONS Ionis Pharmaceuticals (IONS) Soars 6.8%: Is Further Upside Left in the Stock?
Jun 24 HRMY Harmony wins Wakix label extension to include sleepiness in pediatric patients
Jun 24 DNLI Denali Therapeutics (DNLI) Moves 5.8% Higher: Will This Strength Last?
Jun 24 HRMY HARMONY BIOSCIENCES RECEIVES U.S. FOOD AND DRUG ADMINISTRATION APPROVAL FOR WAKIX® (PITOLISANT) IN PEDIATRIC PATIENTS WITH NARCOLEPSY
Jun 24 PTCT PTC Therapeutics (PTCT) Soars 9.7%: Is Further Upside Left in the Stock?
Jun 23 ACAD Acadia Pharmaceuticals: Back In The Buy Zone
Jun 21 ACAD Why Is ACADIA Pharmaceuticals Inc (ACAD) One of the Best Debt Free Halal Stocks According to Hedge Funds?
Jun 21 HRMY Harmony Bio gains as Citi starts at Buy on risk-reward setup
Jun 21 HRMY Praxis Precision Medicines (PRAX) Surges 6.4%: Is This an Indication of Further Gains?
Jun 20 NLSP Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Jun 20 PTCT PTC Therapeutics says FDA lifted partial hold on Huntington's disease program
Jun 20 PTCT PTC Therapeutics Says FDA Lifts Clinical Hold On Investigational Study In Patients With Rare Weak Nerve Cell Disorder
Jun 20 ENZ Zacks Initiates Coverage of Enzo Biochem With Neutral Recommendation
Jun 20 PTCT FDA lifts hold on PTC Huntington’s disease trial
Jun 20 PTCT Interim PIVOT-HD Results Demonstrate Evidence of Favorable CNS Biomarker and Clinical Effects at Month 12 in Huntington's Disease Patients
Jun 19 IONS Ionis (IONS) Expands Licensing Deal With Otsuka for HAE Drug
Neurological Disorders

Neurological disorders are conditions that affect the nervous system, which includes the brain, spinal cord, and nerves. These disorders can affect how the body functions, including movement, speech, and memory. Examples of neurological disorders include Alzheimer's disease, Parkinson's disease, multiple sclerosis, stroke, epilepsy, and migraine.

Browse All Tags